| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Dept. of Health Management, Atlantic Veterinary College, University of Prince Edward Island, Charlottetown, PEI, Canada
Quality Milk Production Services, Cornell University, Ithaca, NY 14850-1263
1 Corresponding author: barkema{at}upei.ca
Staphylococcus aureus is an important cause of udder infections in dairy herds. Both lactational and dry cow therapy are part of Staph. aureus control programs. Reported cure rates for Staph. aureus mastitis vary considerably. The probability of cure depends on cow, pathogen, and treatment factors. Cure rates decrease with increasing age of the cow, increasing somatic cell count, increasing duration of infection, increasing bacterial colony counts in milk before treatment, and increasing number of quarters infected. Staphylococcus aureus mastitis in hind quarters has a low cure rate compared with front quarters. Antimicrobial treatment of intramammary infections with penicillin-resistant Staph. aureus strains results in a lower cure rate for treatment with either ß-lactam or non-ß-lactam antibiotics. Other strain-specific factors may affect the probability of cure but routine diagnostic methods for use in bacteriology laboratories or veterinary practices are not yet available. The most important treatment factor affecting cure is treatment duration. Increased duration of treatment is associated with increased chance of cure. Economically, extended treatment is not always justified, even when indirect effects of treatment such as prevention of contagious transmission are taken into consideration. Usefulness of treatment trials could be improved by standardization of case definitions, consideration of host and strain factors, and sufficient statistical power. Treatment of young animals with penicillin-sensitive Staph. aureus infections is often justified based on bacteriological cure and economic outcome, whereas treatment of older animals, chronic infections, or penicillin-resistant isolates should be discouraged.
Key Words: Staphylococcus aureus • mastitis • treatment • cure
This article has been cited by other articles:
|
|
 |
|
  B. Griesbeck-Zilch, H. H. D. Meyer, CH. Kuhn, M. Schwerin, and O. Wellnitz Staphylococcus aureus and Escherichia coli Cause Deviating Expression Profiles of Cytokines and Lactoferrin Messenger Ribonucleic Acid in Mammary Epithelial Cells J Dairy Sci, June 1, 2008; 91(6): 2215 - 2224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-M. Heikkila, J. I. Nousiainen, and L. Jauhiainen Optimal Replacement Policy and Economic Value of Dairy Cows with Diverse Health Status and Production Capacity J Dairy Sci, June 1, 2008; 91(6): 2342 - 2352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Salat, F. Serieys, B. Poutrel, L. Durel, and L. Goby Systemic Treatment of Subclinical Mastitis in Lactating Cows with Penethamate Hydriodide J Dairy Sci, February 1, 2008; 91(2): 632 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Schmitt-Van de Leemput and R. N. Zadoks Genotypic and Phenotypic Detection of Macrolide and Lincosamide Resistance in Streptococcus uberis J Dairy Sci, November 1, 2007; 90(11): 5089 - 5096. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Smyth, W. J. Meaney, P. J. Hartigan, and C. J. Smyth Occurrence of ssl genes in isolates of Staphylococcus aureus from animal infection J. Med. Microbiol., March 1, 2007; 56(3): 418 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. McDougall, K. E. Agnew, R. Cursons, X. X. Hou, and C. R. W. Compton Parenteral Treatment of Clinical Mastitis with Tylosin Base or Penethamate Hydriodide in Dairy Cattle J Dairy Sci, February 1, 2007; 90(2): 779 - 789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. I. Parker, C. Compton, F. M. Anniss, A. Weir, C. Heuer, and S. McDougall Subclinical and Clinical Mastitis in Heifers Following the Use of a Teat Sealant Precalving J Dairy Sci, January 1, 2007; 90(1): 207 - 218. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
